Cosmos Health Inc. announced preliminary revenue of approximately $54.3 million for the nine months ended September 30, 2026, representing a 19% increase from $45.6 million in the same period of 2025. Third-quarter revenue reached a record $17.4 million, up 40% year over year. The company reaffirmed its full-year 2026 revenue outlook to surpass $90 million. Cosmos Health operates as a diversified, vertically integrated global healthcare group involved in contract manufacturing, pharmaceutical distribution, and proprietary brands.
